Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1981-8-20
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0014-5793
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
6
|
pubmed:volume |
126
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
49-52
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7016582-Crystallization,
pubmed-meshheading:7016582-Escherichia coli,
pubmed-meshheading:7016582-Fourier Analysis,
pubmed-meshheading:7016582-Macromolecular Substances,
pubmed-meshheading:7016582-Methotrexate,
pubmed-meshheading:7016582-Tetrahydrofolate Dehydrogenase,
pubmed-meshheading:7016582-Trimethoprim
|
pubmed:year |
1981
|
pubmed:articleTitle |
The binding of trimethoprim to bacterial dihydrofolate reductase.
|
pubmed:publicationType |
Journal Article
|